Dosimetry of a sonolucent material for an ultrasound -compatible gynecologic high-dose-rate brachytherapy cylinder using Monte Carlo simulation and radiochromic film

被引:6
作者
Van Elburg, Devin J. [1 ,2 ]
Roumeliotis, Michael [1 ,2 ,3 ]
Morrison, Hali [2 ]
Rodgers, Jessica R. [4 ,5 ]
Fenster, Aaron [4 ,5 ]
Meyer, Tyler [1 ,2 ,3 ]
机构
[1] Univ Calgary, Dept Phys & Astron, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada
[2] Tom Baker Canc Clin, Dept Med Phys, Calgary, AB, Canada
[3] Univ Calgary, Dept Oncol, Calgary, AB, Canada
[4] Univ Western Ontario, Sch Biomed Engn, London, ON, Canada
[5] Univ Western Ontario, Robarts Res Inst, London, ON, Canada
基金
加拿大健康研究院;
关键词
Gynecologic brachytherapy; High-dose-rate brachytherapy; 3D ultrasound; Transvaginal ultrasound; Dosimetry; GUIDED ADAPTIVE BRACHYTHERAPY; SOCIETY CONSENSUS GUIDELINES; TRANSRECTAL ULTRASOUND; INTERSTITIAL BRACHYTHERAPY; NEEDLE PLACEMENT; CARCINOMA; CANCER; CT;
D O I
10.1016/j.brachy.2020.08.024
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PURPOSE: he purpose of this study was to study the dosimetric characterization of sonolucent material "TPX"to be used toward gynecologic high-dose-rate brachytherapy treatments using ultrasound-compatible cylinders in non -model-based dose calculation workflows. METHODS: Monte Carlo simulations were performed using EGSnrc application egs_brachy in cylinders of polymethylpentene (TPX) plastic, water, and PMMA. Simulations were performed of five 192Ir sources placed longitudinally in similar to 3.7 cm diameter, 5.0 cm length cylinders (matching physical cylinders used in film measurements). TPX and PMMA dose distributions and percentage depth dose curves were compared relative to water. Film measurements were performed to validate egs_brachy simulations. TPX and PMMA cylinders were placed ina water tank using 3D-printed supports to position film radially and touching the surface of the cylinders. The same five 192Ir dwell positions were delivered as simulated in egs_brachy. RESULTS: The egs_brachy and film percentage depth doses agreed within film uncertainties. The egs_brachy relative dose difference between TPX and water was (0.74 +/- 0.09)% and between PMMA and water was (-0.79 +/- 0.09)% over the dose scoring phantom. Dose differences for TPX and PMMA relative to water were less than +/- 1% within 5 cm of the cylinder surface. CONCLUSIONS: In a solid sonolucent sheath of TPX, the dosimetric differences are comparable with PMMA and other applicator materials in clinical use. No additional uncertainty to dose calculation is introduced when treating through TPX cylinders compared with current applicator materials, and therefore, it is acceptable to perform gynecologic brachytherapy treatments with a sonolucent sheath inserted during radiation delivery. (c) 2021 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:265 / 271
页数:7
相关论文
共 29 条
  • [1] Nuclear Data Sheets for A=192
    Baglin, Coral M.
    [J]. NUCLEAR DATA SHEETS, 2012, 113 (8-9) : 1871 - 2111
  • [2] Report of the Task Group 186 on model-based dose calculation methods in brachytherapy beyond the TG-43 formalism: Current status and recommendations for clinical implementation
    Beaulieu, Luc
    Tedgren, Asa Carlsson
    Carrier, Jean-Francois
    Davis, Stephen D.
    Mourtada, Firas
    Rivard, Mark J.
    Thomson, Rowan M.
    Verhaegen, Frank
    Wareing, Todd A.
    Williamson, Jeffrey F.
    [J]. MEDICAL PHYSICS, 2012, 39 (10) : 6208 - 6236
  • [3] American Brachytherapy Society consensus guidelines for interstitial brachytherapy for vaginal cancer
    Beriwal, Sushil
    Demanes, D. Jeffrey
    Erickson, Beth
    Jones, Ellen
    De Los Santos, Jennifer F.
    Cormack, Robert A.
    Yashar, Catheryn
    Rownd, Jason J.
    Viswanathan, Akila N.
    [J]. BRACHYTHERAPY, 2012, 11 (01) : 68 - 75
  • [4] egs_brachy: a versatile and fast Monte Carlo code for brachytherapy
    Chamberland, Marc J. P.
    Taylor, Randle E. P.
    Rogers, D. W. O.
    Thomson, Rowan M.
    [J]. PHYSICS IN MEDICINE AND BIOLOGY, 2016, 61 (23) : 8214 - 8231
  • [5] Monte Carlo-aided dosimetry of a new high dose-rate brachytherapy source
    Daskalov, GM
    Loffler, E
    Williamson, JF
    [J]. MEDICAL PHYSICS, 1998, 25 (11) : 2200 - 2208
  • [6] Brachytherapy: A critical component of primary radiation therapy for cervical cancer: From the Society of Gynecologic Oncology (SGO) and the American Brachytherapy Society (ABS)
    Holschneider, Christine H.
    Petereit, Daniel G.
    Chu, Christina
    Hsu, I. -Chow
    Ioffe, Yevgeniya J.
    Klopp, Ann H.
    Pothuri, Bhavana
    Chen, Lee-may
    Yashar, Catheryn
    [J]. BRACHYTHERAPY, 2019, 18 (02) : 123 - 132
  • [7] Clinical outcomes of high-dose-rate interstitial gynecologic brachytherapy using real-time CT guidance
    Lee, Larissa J.
    Damato, Antonio L.
    Viswanathan, Akila N.
    [J]. BRACHYTHERAPY, 2013, 12 (04) : 303 - 310
  • [8] Massillon-Jl G., 2012, Int J Med Phys Clin Eng Radiation Oncol, V1, P60, DOI DOI 10.1118/1.4735153
  • [9] Comparison of CTVHR and organs at risk contours between TRUS and MR images in IB cervical cancers: a proof of concept study
    Mendez, Lucas C.
    Ravi, Ananth
    Martell, Kevin
    Raziee, Hamid
    Alayed, Yasir
    Wronski, Matt
    Paudel, Moti
    Barnes, Elizabeth
    Taggar, Amandeep
    Wong, C. S.
    Leung, Eric
    [J]. RADIATION ONCOLOGY, 2020, 15 (01)
  • [10] A framework for clinical commissioning of 3D-printed patient support or immobilization devices in photon radiotherapy
    Meyer, Tyler
    Quirk, Sarah
    D'Souza, Malgorzata
    Spencer, David
    Roumeliotis, Michael
    [J]. JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 2018, 19 (05): : 499 - 505